Aspira Pathlab & Diagnostics Limited
ASPIRA · NSEon the next trading day
Valuation
Blended fair value using DCF and peer comparison methods.
The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Healthcare · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
Aspira Pathlab & Diagnostics Limited ASPIRA · you | ₹102 Cr | -226.1× | 9.2× | — | -4.1% | -0.0% | — |
| Sector median | — | 34.0× | 2.7× | 13.4× | 4.8% | 0.1% | 7.8% |
| Health X Platform Limited HEALTHX | ₹954 Cr | 796.5× | 1.5× | — | 0.2% | 0.1% | 8.3% |
| Bharat Parenterals Limited BPLPHARMA | ₹930 Cr | 96.0× | 2.9× | — | 3.0% | 0.1% | — |
| Wanbury Limited WANBURY | ₹915 Cr | 16.4× | 23.6× | — | 144.2% | 0.0% | — |
| Kopran Limited KOPRAN | ₹893 Cr | 34.0× | 1.6× | 13.4× | 4.8% | 3.8% | 7.3% |
| Anlon Healthcare Limited AHCL | ₹846 Cr | 23.3× | 3.3× | 18.6× | 12.6% | 16.9% | 15.1% |
| Amanta Healthcare Limited AMANTA | ₹696 Cr | 35.4× | 2.7× | 13.4× | 6.8% | 5.2% | 3.5% |
| ZIM Laboratories Limited ZIMLAB | ₹588 Cr | 154.4× | 2.5× | — | 1.6% | -0.0% | — |
| Hemant Surgical Industries Limited HSIL | ₹531 Cr | 29.1× | — | — | — | — | — |
Aspira trades at a discount to sector peers on P/E (-226.1× vs median 34.0×). This may signal undervaluation — or reflect lower expected growth or higher perceived risk versus the peer group.
Business quality
Valuation
Returns
Growth
Efficiency
Liquidity & Solvency
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.